Literature DB >> 12497639

Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps.

Iris Eisenberg1, Gil Grabov-Nardini, Hagit Hochner, Mira Korner, Menachem Sadeh, Tulio Bertorini, Kate Bushby, Claudio Castellan, Kevin Felice, Jerry Mendell, Luciano Merlini, Christopher Shilling, Itshak Wirguin, Zohar Argov, Stella Mitrani-Rosenbaum.   

Abstract

Hereditary Inclusion Body Myopathy (HIBM) is a unique group of neuromuscular disorders characterized by adult onset and a typical muscle pathology. We have recently identified the gene encoding for a bifunctional enzyme, UDP-N-acetylglucosamine 2 epimerase/N-acetylmannosamine kinase (GNE), as the mutated gene in the prototype form of the disease presenting quadriceps sparing, particularly common in Middle Eastern Jews. Interestingly, we have identified the homozygous M712T Middle Eastern Jewish mutation also in two unrelated Middle Eastern Moslem families. We have also evaluated the involvement of GNE in several families from worldwide non-Jewish ethnic origins presenting symptoms similar to the Middle Eastern HIBM prototype. A total of 14 GNE mutations were identified (one nonsense and 13 missense), of which six are novel: an homozygous missense mutation in a consanguineous family from Italy and in a non consanguineous family from USA, and distinct compound heterozygotes in families from Germany, Italy, Ireland, Bahamas, USA and East India. This study brings to 17 the number of reported GNE mutations in quadriceps sparing myopathy, occurring either in the epimerase or the kinase domain of the enzyme. The mechanism leading to this unique phenotype still remains to be elucidated. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12497639     DOI: 10.1002/humu.9100

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  38 in total

1.  Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex.

Authors:  Gregory Nemunaitis; Chris M Jay; Phillip B Maples; William A Gahl; Marjan Huizing; Tal Yardeni; Alex W Tong; Anagha P Phadke; Beena O Pappen; Cynthia Bedell; Henry Allen; Cathy Hernandez; Nancy S Templeton; Joseph Kuhn; Neil Senzer; John Nemunaitis
Journal:  Hum Gene Ther       Date:  2011-04-25       Impact factor: 5.695

2.  Clinical features, lectin staining, and a novel GNE frameshift mutation in hereditary inclusion body myopathy.

Authors:  N C Voermans; M Guillard; R Doedée; M Lammens; M Huizing; G W Padberg; R A Wevers; B G van Engelen; D J Lefeber
Journal:  Clin Neuropathol       Date:  2010 Mar-Apr       Impact factor: 1.368

3.  Mutation analysis of the GNE gene in Korean patients with distal myopathy with rimmed vacuoles.

Authors:  Byoung Joon Kim; Chang-Seok Ki; Jong-Won Kim; Duk Hyun Sung; Young-Chul Choi; Seung Hyun Kim
Journal:  J Hum Genet       Date:  2005-12-22       Impact factor: 3.172

4.  Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice.

Authors:  Masashi Kitazawa; Kim N Green; Antonella Caccamo; Frank M LaFerla
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

5.  Sizing up sialic acid in glomerular disease.

Authors:  Susan E Quaggin
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

6.  Distal myopathy with rimmed vacuoles: Spectrum of GNE gene mutations in seven Chinese patients.

Authors:  Feifei Su; Jing Miao; Xuemei Liu; Xiaojing Wei; Xuefan Yu
Journal:  Exp Ther Med       Date:  2018-06-22       Impact factor: 2.447

7.  GNE Myopathy and Cell Apoptosis: A Comparative Mutation Analysis.

Authors:  Reema Singh; Ranjana Arya
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

8.  Biochemical characterization of human and murine isoforms of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE).

Authors:  Stefan O Reinke; Colin Eidenschink; Chris M Jay; Stephan Hinderlich
Journal:  Glycoconj J       Date:  2008-09-23       Impact factor: 2.916

9.  Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.

Authors:  Anagha P Phadke; Chris Jay; Salina J Chen; Courtney Haddock; Zhaohui Wang; Yang Yu; Derek Nemunaitis; Gregory Nemunaitis; Nancy S Templeton; Neil Senzer; Phillip B Maples; Alex W Tong; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-05-08

10.  Hereditary Inclusion Body Myopathy (HIBM2).

Authors:  Chris M Jay; Nick Levonyak; Gregory Nemunaitis; Phillip B Maples; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.